Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2GVdbzq
via IFTTT